SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950116-05-000744
Filing Date
2005-02-23
Accepted
2005-02-23 12:44:34
Documents
1
Period of Report
2005-03-24
Effectiveness Date
2005-02-23

Document Format Files

Seq Description Document Type Size
1 def-14a.txt DEF 14A 132090
  Complete submission text file 0000950116-05-000744.txt   133655
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 05633542
SIC: 2834 Pharmaceutical Preparations